Skip Navigation

Cardiovascular Research 2004 61(1):115-122; doi:10.1016/j.cardiores.2003.11.003
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Argaud, L.
Right arrow Articles by Ovize, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Argaud, L.
Right arrow Articles by Ovize, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Preconditioning delays Ca2+-induced mitochondrial permeability transition

Laurent Argauda, Odile Gateau-Roescha, Lara Chalabreysseb, Ludovic Gomeza, Joseph Loufouata, Françoise Thivolet-Béjuib, Dominique Robertc and Michel Ovize*,a

aINSERM E0226, Laboratoire de Physiologie Lyon-Nord, Université Claude Bernard Lyon I, 8, Avenue Rockefeller, 69373 Lyon, France
bLaboratoire d'Anatomie Pathologique, Hôpital Louis Pradel, Lyon, France
cDépartement d'Urgence et de Réanimation Médicale, Hôpital Edouard Herriot, Lyon, France

* Corresponding author. Tel.: +33-4-7877-7074; fax: +33-4-7877-7175. laurent.argaud{at}chu-lyon.fr, ovize{at}rockefeller.univ-lyon1.fr

Objective: We investigated whether ischemic preconditioning (PC) may modify mitochondrial permeability transition (MPT) pore opening. Methods: In protocol 1, New Zealand White rabbits underwent either no intervention (sham group) or 10 min of ischemia followed by 5 min of reperfusion, preceded (PC) or not (C; control) by one episode of 5 min of ischemia and 5 min of reperfusion. Rabbits were pretreated by either saline or the MPT pore inhibitor cyclosporin A (CsA), or its non-immunosuppressive derivative Cs29 (10 mg/kg, IV bolus). Hearts were harvested and mitochondria isolated for further assessment of Ca2+-induced MPT using a Ca2+-sensitive micro-electrode. In protocol 2, C and PC hearts underwent 30 min of ischemia and 4 h of reperfusion. They were pretreated either by saline, CsA or Cs29, as in protocol 1. Infarct size was assessed by triphenyltetrazolium, and apoptosis by TUNEL staining. Results: In protocol 1, the Ca2+ overload required to induce MPT pore opening was significantly higher in PC than in C hearts. CsA and Cs29 significantly increased the Ca2+ overload required for MPT pore opening. In protocol 2, mean infarct size averaged 25% of the risk region in CsA/Cs29 treated hearts versus 15% in PC and 55% in controls (P<0.05 vs. C, P = ns vs. PC). Cardiomyocyte apoptosis was significantly reduced by PC and cyclosporin treatment with a mean apoptotic index of less than 2% in either group versus more than 11% in controls. Conclusion: This suggests that delayed opening of MPT pore may play a major role in ischemic PC.

KEYWORDS Preconditioning; Calcium (cellular); Mitochondria; Apoptosis; Necrosis


Time for primary review 22 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. Gomez, B. Li, N. Mewton, I. Sanchez, C. Piot, M. Elbaz, and M. Ovize
Inhibition of mitochondrial permeability transition pore opening: translation to patients
Cardiovasc Res, July 15, 2009; 83(2): 226 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Paris, C. Perez-Pastene, E. Couve, P. Caviedes, S. LeDoux, and J. Segura-Aguilar
Copper{middle dot}Dopamine Complex Induces Mitochondrial Autophagy Preceding Caspase-independent Apoptotic Cell Death
J. Biol. Chem., May 15, 2009; 284(20): 13306 - 13315.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. T. Yocum, J. G. Gaudet, S. S. Lee, Y. Stern, L. A. Teverbaugh, R. R. Sciacca, C. W. Emala, D. O. Quest, P. C. McCormick, J. F. McKinsey, et al.
Inducible Nitric Oxide Synthase Promoter Polymorphism Affords Protection Against Cognitive Dysfunction After Carotid Endarterectomy
Stroke, May 1, 2009; 40(5): 1597 - 1603.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. B. West, G. Rokosh, D. Obal, M. Velayutham, Y.-T. Xuan, B. G. Hill, R. J. Keith, J. Schrader, Y. Guo, D. J. Conklin, et al.
Cardiac Myocyte-Specific Expression of Inducible Nitric Oxide Synthase Protects Against Ischemia/Reperfusion Injury by Preventing Mitochondrial Permeability Transition
Circulation, November 4, 2008; 118(19): 1970 - 1978.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. E. McAllister, H. Ashrafpour, N. Cahoon, N. Huang, M. A. Moses, P. C. Neligan, C. R. Forrest, J. E. Lipa, and C. Y. Pang
Postconditioning for salvage of ischemic skeletal muscle from reperfusion injury: efficacy and mechanism
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R681 - R689.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. D. T. Costa and K. D. Garlid
Intramitochondrial signaling: interactions among mitoKATP, PKC{varepsilon}, ROS, and MPT
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H874 - H882.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol, N. Mewton, R. Elbelghiti, T. T. Cung, E. Bonnefoy, D. Angoulvant, et al.
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
N. Engl. J. Med., July 31, 2008; 359(5): 473 - 481.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. N. Obame, C. Plin-Mercier, R. Assaly, R. Zini, J. L. Dubois-Rande, A. Berdeaux, and D. Morin
Cardioprotective Effect of Morphine and a Blocker of Glycogen Synthase Kinase 3{beta}, SB216763 [3-(2,4-Dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via Inhibition of the Mitochondrial Permeability Transition Pore
J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 252 - 258.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Gomez, M. Paillard, H. Thibault, G. Derumeaux, and M. Ovize
Inhibition of GSK3{beta} by Postconditioning Is Required to Prevent Opening of the Mitochondrial Permeability Transition Pore During Reperfusion
Circulation, May 27, 2008; 117(21): 2761 - 2768.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. J. Clarke, I. Khaliulin, M. Das, J. E. Parker, K. J. Heesom, and A. P. Halestrap
Inhibition of Mitochondrial Permeability Transition Pore Opening by Ischemic Preconditioning Is Probably Mediated by Reduction of Oxidative Stress Rather Than Mitochondrial Protein Phosphorylation
Circ. Res., May 9, 2008; 102(9): 1082 - 1090.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.